Dow Up 0.05% Nasdaq Up 0.17%

Celgene Corporation (CELG)

-NasdaqGS
118.23 Down 1.23(1.03%) Feb 24, 4:00PM EST
|After Hours : 118.43 Up 0.20 (0.17%) Feb 24, 6:07PM EST
Prev Close:119.46
Open:118.50
Bid:117.70 x 200
Ask:118.39 x 200
1y Target Est:140.33
Beta:1.51584
Earnings Date:Apr 26 - May 1 (Est.)
Day's Range:117.28 - 119.31
52wk Range:94.39 - 127.00
Volume:4,485,995
Avg Vol (3m):4,224,510
Market Cap:91.98B
P/E (ttm):47.48
EPS (ttm):2.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CELG

Comparison

Symbol% ChgMkt Cap
CELGDown 1.03%91.98B
1 0.00%N/A
JNJUp 1.51%333.89B

Key Statistics

Forward P/E (1 yr):13.48
P/S (ttm):8.28
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-17) :7.22
Quarterly EPS Est (Mar-17) :1.63
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.74

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lym... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback